Close

content

Perigord becomes the most certified supplier of artwork solutions to the Life Science industry

Perigord confirms, that in achieving its latest certification ISO 27001, that they are the only Global provider of Artwork Management Systems (AMS) to the...

LANXESS disinfectant kills coronavirus SARS-CoV-2 in just 60 seconds

Rely+On Virkon broad spectrum disinfectant, produced by specialty Chemicals Company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus. This is the finding of a...

Clinerion protects security of Patient Network Explorer user accounts with 2-step authentication

The “Clinerion PNEx Authenticator” app gives users of Clinerion’s Patient Network Explorer additional data security with 2-step authentication. To protect Patient Network Explorer user accounts...

Evotec and Novo Nordisk form strategic alliance to develop novel therapies for kidney diseases

Evotec SE and Novo Nordisk announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease. Evotec and...

BMS and Dragonfly Therapeutics Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program

Bristol Myers Squibb and Dragonfly Therapeutics, Inc. announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted...

Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration

Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies...

Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in Colon Cancer

Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read